Sanctuary Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Sanctuary Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	3,335 +600	+22%	+$62.1K	﹤0.01%	2194
2026 Q1	$284K	Sell	2,735 -600	-18%	-$63.9K	﹤0.01%	2128
2025 Q4	$344K	Buy	3,335 +480	+17%	+$46.7K	﹤0.01%	1936
2025 Q3	$258K	Buy	2,855 +300	+12%	+$26.3K	﹤0.01%	2093
2025 Q2	$225K	Buy	2,555 +185	+8%	+$16K	﹤0.01%	2095
2025 Q1	$216K	Buy	+2,370	New	+$213K	﹤0.01%	1995
2024 Q4	–	Sell	-2,358	Closed	-$209K	–	2472
2024 Q3	$209K	Sell	2,358 -41,736	-95%	-$3.96M	﹤0.01%	2204
2024 Q2	$3.83M	Buy	+44,094	New	+$3.94M	0.03%	550

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Sanctuary Advisors's PPH Position: Q2 2026 in Review

Sanctuary Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 22% in Q2 2026, buying an estimated $62.1K and bringing the position to 3,335 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Sanctuary Advisors first reported a position in PPH in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.83M in Q2 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Sanctuary Advisors held 3,335 shares of VanEck Pharmaceutical ETF worth $365K as of Q2 2026.
Sanctuary Advisors bought 600 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $62.1K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2194 holding.
Sanctuary Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 8 quarters since.
Sanctuary Advisors's VanEck Pharmaceutical ETF position peaked at $3.83M in Q2 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.